Abstract
Objective: While gynaecological cancer patients who participate in Phase I clinical trials are not routinely considered for elective surgery because of a short life expectancy, this should not be overlooked in carefully selected responding patients. Methods/Results: We describe two cases of patients with different gynaecological cancers, who received treatment within separate phase I trials, and who then proceeded to surgical resection of their cancers, resulting in complete remission. Conclusion: Surgery, when feasible, should be taken into consideration as a potential management option, even when patients are receiving treatment within a phase I trial.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 211-213 |
| Number of pages | 3 |
| Journal | European Journal of Gynaecological Oncology |
| Volume | 33 |
| Issue number | 2 |
| State | Published - May 22 2012 |
| Externally published | Yes |
Keywords
- Gynaecological cancers
- Phase I trial
- Surgery
ASJC Scopus subject areas
- Oncology
- Obstetrics and Gynecology